表紙
市場調査レポート

世界の心臓ポイントオブケア(POC)市場

Global Cardiac POC Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 310044
出版日 ページ情報 英文 63 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
世界の心臓ポイントオブケア(POC)市場 Global Cardiac POC Market 2014-2018
出版日: 2014年08月06日 ページ情報: 英文 63 Pages
概要

心臓ポイントオブケア(POC)は、患者のそば(ベッドサイド)で医療検査を行うことです。心臓POCは、コレステロールと凝固検査を含む、簡易な医療血液検査です。世界の心臓POC市場は、2013年〜2018年のCAGRで、14.40%の成長が見込まれています。

当レポートでは、世界の心臓POC市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 市場区分:検査タイプ別

第8章 世界の心臓トロポニン検査市場

  • 市場概要
  • 市場規模と予測

第9章 世界の心臓BNP検査市場

  • 市場概要
  • 市場規模と予測

第10章 地域区分

第11章 購買基準

第12章 市場成長促進要因

第13章 促進要因とその影響

第14章 市場課題

第15章 促進要因と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第19章 主要ベンダー分析

  • 事業概要、主要情報、SWOT分析など
    • Abbott Laboratories
    • Alere
    • Roche Diagnostics

図表

目次
Product Code: IRTNTR3914

About Cardiac POC

Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients.

TechNavio's analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT.

The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

TechNavio's report, the Global Cardiac POC Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cardiac POC market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Alere Inc.
  • Abbott Laboratories
  • Roche Diagnostics

Other Prominent Vendors

  • Beckman Coulter, Inc.
  • BG Medicine Inc.
  • Boston Scientific Corp
  • Medtronic Inc.
  • Randox Laboratories Ltd.

Key Market Driver

  • Increasing Incidence of Cardiac Disorders.

For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Specific Actions in Detecting the Presence of Cardiovascular Diseases.

For a full, detailed list, view our report.

Key Market Trend

  • Introduction of Enhanced Products.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Type of Tests

08. Global Cardiac Troponin Test Market

  • 08.1. Market Overview
  • 08.2. Market Size and Forecast

09. Global Cardiac BNP Test Market

  • 09.1. Market Overview
  • 09.2. Market Size and Forecast

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2013
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories
    • 19.1.1. Key Facts
    • 19.1.2. Business Overview
    • 19.1.3. Business Segmentation by Revenue 2012
    • 19.1.4. Business Segmentation by Revenue 2012 and 2013
    • 19.1.5. Sales by Geography
    • 19.1.6. Business Strategy
    • 19.1.7. Key Developments
    • 19.1.8. SWOT Analysis
    • 19.1.9. Strengths
    • 19.1.10. Weakness
    • 19.1.11. Opportunities
    • 19.1.12. Threats
  • 19.2. Alere
    • 19.2.1. Business Overview
    • 19.2.2. Business Segmentation
    • 19.2.3. Business Segmentation by Revenue 2013
    • 19.2.4. Geographical Segmentation by Revenue 2013
    • 19.2.5. Business Strategy
    • 19.2.6. Recent Developments
    • 19.2.7. SWOT Analysis
    • 19.2.8. Strengths
    • 19.2.9. Weaknesses
    • 19.2.10. Opportunities
    • 19.2.11. Threats
  • 19.3. Roche Diagnostics
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation by Revenue 2013
    • 19.3.4. Geographical Segmentation by Revenue 2013
    • 19.3.5. Business Strategy
    • 19.3.6. Recent Developments
    • 19.3.7. SWOT Analysis
    • 19.3.8. Strengths
    • 19.3.9. Weaknesses
    • 19.3.10. Opportunities
    • 19.3.11. Threats
    • 19.3.12. Other Reports in Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Cardiac POC Market for 2013-2018 in (US$ million)
  • Exhibit 3: Global Cardiac POC Market Segmentation by Type of Test
  • Exhibit 4: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018 in (US$ million)
  • Exhibit 5: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018
  • Exhibit 6: Global Cardiac Troponin Test Market 2013-2018 (US$ million)
  • Exhibit 7: Global Cardiac BNP Test Market 2013-2018 (US$ million)
  • Exhibit 8: Global Cardiac POC Market by Geographical Segmentation 2013
  • Exhibit 9: Global Cardiac POC Market Vendor Share Analysis 2013
  • Exhibit 10: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 11: Abbott Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 12: Abbott Laboratories: Sales by Geography 2012
  • Exhibit 13: Business Segmentation of Alere
  • Exhibit 14: Alere Business Segmentation by Revenue 2013
  • Exhibit 15: Alere Geographical Segmentation by Revenue 2013
  • Exhibit 16: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 17: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Back to Top